The most well described defect in the pathophysiology of T2D is reduced insulin stimulated glycogen synthase activity [31], [32] and this was demonstrable in myotubes established from subjects with T2D [20], [22]. This evidence concerns the gene INS and type 2 diabetes mellitus.